Intervention Review

You have free access to this content

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

  1. Kayleigh M Kew1,*,
  2. Sofia Dias2,
  3. Christopher J Cates1

Editorial Group: Cochrane Airways Group

Published Online: 26 MAR 2014

Assessed as up-to-date: 5 SEP 2013

DOI: 10.1002/14651858.CD010844.pub2


How to Cite

Kew KM, Dias S, Cates CJ. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010844. DOI: 10.1002/14651858.CD010844.pub2.

Author Information

  1. 1

    St George's, University of London, Population Health Research Institute, London, UK

  2. 2

    University of Bristol, School of Social and Community Medicine, Bristol, UK

*Kayleigh M Kew, Population Health Research Institute, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. kkew@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 26 MAR 2014

SEARCH

[Figure 1]
Figure 1. Study flow diagram.aAll 58 studies identified in the review search were also identified in the electronic database search.Abbreviations: CDSR = Cochrane Database of Systematic Reviews.
[Figure 2]
Figure 2. Network structures for both outcomes at six months.
[Figure 3]
Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Figure 4]
Figure 4. St George's Respiratory Questionnaire (SGRQ) change from baseline—six-month and 12-month class results.
[Figure 5]
Figure 5. Trough forced expiratory volume in one second (FEV1) change from baseline—six-month and 12-month class results.
[Figure 6]
Figure 6. St George's Respiratory Questionnaire (SGRQ) probability ranking diagrams—six months and 12 months.
[Figure 7]
Figure 7. Forced expiratory volume in one second (FEV1) probability ranking diagrams—six months and 12 months.